nf1 glutathione loss of function as an alternative initiating event in pancreatic ductal adenocarcinoma Personalized pharmacokinetic–pharmacodynamic guided therapy via
Personalized pharmacokineticpharmacodynamic guided therapy via an induced pluripotent stem cellderived multi organoid platform in NF1 mutant breast cancer Signal Transduction and Targeted Therapy NRF2 activation by cysteine as a survival mechanism for triple negative breast cancer cells Oncogene Fountain Health NYC Glutathione Therapy neurofibromotosis glutathione Cutaneous neurofibromas in the genomics era: current understanding and open questions The Contribution of Oxidative Stress
Pay in 4 interest-free payments of $7.44 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 7 - Aug 12



